Column Group III Amends Surrozen Stake Filing
Ticker: SRZNW · Form: SC 13D/A · Filed: Apr 17, 2024 · CIK: 1824893
| Field | Detail |
|---|---|
| Company | Surrozen, Inc./De (SRZNW) |
| Form Type | SC 13D/A |
| Filed Date | Apr 17, 2024 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 9 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: schedule-13d, amendment, beneficial-ownership
Related Tickers: SRZN
TL;DR
Column Group III updated their Surrozen stake filing on 4/17. Watch SRZN.
AI Summary
On April 17, 2024, The Column Group III, LP, along with its affiliates COLUMN GROUP III-A, LP and TIM KUTZKEY, filed an amendment to their Schedule 13D. This filing indicates a change in beneficial ownership of Surrozen, Inc. (NASDAQ: SRZN). The filing does not specify a new percentage of ownership or dollar amount, but it is an update to their previous filings regarding their stake in the company.
Why It Matters
This filing signals a potential shift in major shareholder activity for Surrozen, Inc., which could influence stock price and corporate strategy.
Risk Assessment
Risk Level: medium — Schedule 13D filings often precede significant corporate actions or shifts in control, which can introduce volatility.
Key Players & Entities
- The Column Group III, LP (company) — Filing entity
- Surrozen, Inc. (company) — Subject company
- COLUMN GROUP III-A, LP (company) — Affiliated filing entity
- TIM KUTZKEY (person) — Affiliated filing entity
- James Evangelista (person) — Chief Financial Officer of The Column Group III, LP
FAQ
What specific changes in beneficial ownership are reported in this amendment?
The filing is an amendment (Amendment No. 3) to a Schedule 13D, indicating a change in beneficial ownership, but the specific percentage or number of shares acquired or disposed of is not detailed in the provided header information.
What is the CUSIP number for Surrozen, Inc. common stock?
The CUSIP number for Surrozen, Inc. common stock is 86889P 208.
Who is filing this amendment?
The amendment is being filed by The Column Group III, LP, along with group members COLUMN GROUP III-A, LP and TIM KUTZKEY.
When was this filing submitted to the SEC?
This filing was submitted on April 17, 2024.
What is Surrozen, Inc.'s primary business?
Surrozen, Inc. is in the Biological Products (No Diagnostic Substances) industry, SIC code 2836.
Filing Stats: 2,223 words · 9 min read · ~7 pages · Grade level 17.4 · Accepted 2024-04-17 16:10:26
Key Financial Figures
- $0.0001 — INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o
Filing Documents
- d825926dsc13da.htm (SC 13D/A) — 82KB
- 0001193125-24-099085.txt ( ) — 84KB
From the Filing
SC 13D/A 1 d825926dsc13da.htm SC 13D/A SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) SURROZEN, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 86889P 208 (CUSIP Number) James Evangelista Chief Financial Officer The Column Group III, LP 1 Letterman Drive, Building D, Suite M-900 San Francisco, CA 94129 (415) 865-2050 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) April 4, 2024 (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following pages) CUSIP No. 86889P 208 13D 1 NAMES OF REPORTING PERSONS The Column Group III GP, LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (see instructions) AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 8 SHARED VOTING POWER 1,225,273 (1) 9 SOLE DISPOSITIVE POWER 0 10 SHARED DISPOSITIVE POWER 1,225,273 (1) 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,225,273 (1) 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 33.9% (2) 14 TYPE OF REPORTING PERSON (see instructions) PN (1) Consists of (i) 380,446 shares of Common Stock held of record by TCG III LP (as defined in Item 2(a) below), (ii) warrants to purchase 194,985 shares of Common Stock held by TCG III LP which are exercisable within 60 days of this Statement, (iii) 429,643 shares of Common Stock held of record by TCG III-A LP (as defined in Item 2(a) below) and (iv) warrants to purchase 220,199 shares of Common Stock held by TCG III-A LP which are exercisable within 60 days of this Statement. This total excludes (a) warrants to purchase 704,450 shares of Common Stock held by TCG III, LP, which are not exercisable within 60 days of this Statement and (b) warrants to purchase 795,546 shares of Common Stock held by TCG III-A, LP, which are not exercisable within 60 days of this Statement. TCG III GP LP is the general partner of each of TCG III LP and TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. Peter Svennilson, David Goeddel and Tim Kutzkey, a member of the Issuers board of directors, are the managing partners of TCG III GP LP and may each be deemed to share voting, investment and dispositive power with respect to these securities. (2) Based on (i) 2,106,805 shares of Common Stock outstanding as of March 31, 2024, as reported by the Issuer to the Reporting Persons plus (ii) 1,091,981 shares of Common Stock sold by the Issuer in the Private Placement (as defined in Item 4 below) as reported in its Current Report on Form 8-K filed with the Securities and Exchange Commission (the Commission ) on April 2, 2024 (the Form 8-K ) plus (iii) 194,985 shares underlying warrants to purchase shares of Common Stock held by TCG III LP which are exercisable within 60 days of this Statement and (iv) 220,199 shares underlying warrants to purchase shares of Common Stock held by TCG III-A LP which are exercisable within 60 days of this Statement. CUSIP No. 86889P 208 13D 1 NAMES OF REPORTING PERSONS The Column Group III, LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (see instructions) WC 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 8 SHARED VOTING POWER 575,431 (1) 9 SOLE DISPOSITIVE POWER 0 10 SHARED DISPOSITIVE POWER 575,431 (1) 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON